Clinical Trial

Effect of Smartphone Application (MED-AD) on Medication Adherence Among Patients With Cardiovascular Disease in Oman

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated April 30, 2026 (before its estimated June 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to: 1. Investigate the impact of MED-AD intervention on medication adherence among CVD patients, compared to patients receiving text message reminders or routine care alone at baseline, 6 months, and 12 months later. 2. Evaluate the effectiveness of MED-AD intervention on clinical outcomes among patients with CVD, compared to the outcomes of patients receiving text or routine care alone at baseline, 6 months, and 12 months later. This study is a prospective randomized controlled clinical trial (RCT) with three arms: 1. MED-AD intervention: MED-AD is a smartphone application that will use the following strategies (pill reminders, Medication Adherence Report, medication intake confirmation, Medical Appointment Reminder, and educational notifications) to enhance medication adherence 2. Text message reminders: Participants will receive short text message (SMS) reminders to remind them to take medications as prescribed once daily 3. Routine care only: Participants will receive routine care that does not include text messages or reminders and education through an application.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-26.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-04-26
Trial Details
NCT Number NCT06951451
Lead Sponsor Sultan Qaboos University
Conditions Ischemic Cardiovascular Disease, Hypertension, Hyperlipidemia
Enrollment 1,000 participants
Start Date 2025-06-01
Primary Completion 2026-06-28 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-30